Biomark Diagnostics Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	35	14	17	10	11	21
Market Cap Growth	213.32%	-15.29%	61.96%	-7.18%	-45.46%	140.92%
Enterprise Value	35	15	18	12	12	21
Last Close Price	0.34	0.14	0.19	0.13	0.14	0.27
PS Ratio	467.57	145.04	152.12	100.50	356.91	-
PB Ratio	66.83	12.85	-40.73	-13.42	-24.67	-386.98
P/TBV Ratio	66.83	12.85	-	-	-	-
EV/Sales Ratio	-	154.52	161.35	110.73	393.16	-
Debt / Equity Ratio	0.93	0.64	-2.54	-1.44	-3.09	-12.70
Net Debt / Equity Ratio	-0.86	-0.78	-2.28	-1.37	-2.49	-1.61
Net Debt / EBITDA Ratio	0.43	0.67	-0.82	-0.86	-1.24	-0.12
Net Debt / FCF Ratio	0.53	1.24	-1.41	-1.72	-1.25	-0.16
Asset Turnover	0.09	0.07	0.18	0.14	0.04	-
Quick Ratio	1.73	2.14	0.16	0.06	0.31	0.98
Current Ratio	1.73	2.14	0.16	0.08	0.33	1.00
Return on Equity (ROE)	-	-340.70%	-	-	-	-
Return on Assets (ROA)	-79.14%	-60.59%	-117.29%	-104.38%	-66.20%	-80.77%
Return on Capital Employed (ROCE)	-197.50%	-107.60%	1099.30%	197.40%	4328.70%	-3366.60%
Earnings Yield	-2.87%	-8.62%	-5.75%	-11.94%	-9.27%	-3.57%
FCF Yield	-2.46%	-4.90%	-3.98%	-5.96%	-8.06%	-2.64%
Buyback Yield / Dilution	-10.10%	-6.67%	-2.97%	-6.22%	-6.31%	-2.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.